Levels of IL27, a regulatory cytokine in the IL23/17 pathway, are reduced in patients with ERA and this negatively correlates with Th17 cell concentration, suggesting dysregulation of the IL23/IL17 pathway is important in ERA (31). The gene discussed is IL17A; the disease is enthesitis-related juvenile idiopathic arthritis.